+1 (704) 266-3234

Global Malaria Vaccines Market Research Report 2021

Published on: Jan 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 92

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine

Segment by Application
Hospitals
Clinics
Community Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
GlaxoSmithKline Plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec

1 Malaria Vaccines Market Overview
1.1 Product Overview and Scope of Malaria Vaccines
1.2 Malaria Vaccines Segment by Type
1.2.1 Global Malaria Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Pre-Erythrocytic Vaccine
1.2.3 Erythrocytic Vaccine
1.2.4 Multi-antigen Vaccine
1.3 Malaria Vaccines Segment by Application
1.3.1 Malaria Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Community Centers
1.4 Global Malaria Vaccines Market Size Estimates and Forecasts
1.4.1 Global Malaria Vaccines Revenue 2016-2027
1.4.2 Global Malaria Vaccines Sales 2016-2027
1.4.3 Malaria Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Malaria Vaccines Market Competition by Manufacturers
2.1 Global Malaria Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Malaria Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Malaria Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Malaria Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Malaria Vaccines Market Competitive Situation and Trends
2.5.1 Malaria Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Malaria Vaccines Players Market Share by Revenue
2.5.3 Global Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Malaria Vaccines Retrospective Market Scenario by Region
3.1 Global Malaria Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Malaria Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Malaria Vaccines Market Facts & Figures by Country
3.3.1 North America Malaria Vaccines Sales by Country
3.3.2 North America Malaria Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Malaria Vaccines Market Facts & Figures by Country
3.4.1 Europe Malaria Vaccines Sales by Country
3.4.2 Europe Malaria Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Malaria Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Malaria Vaccines Sales by Region
3.5.2 Asia Pacific Malaria Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Malaria Vaccines Market Facts & Figures by Country
3.6.1 Latin America Malaria Vaccines Sales by Country
3.6.2 Latin America Malaria Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Malaria Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Malaria Vaccines Sales by Country
3.7.2 Middle East and Africa Malaria Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Malaria Vaccines Historic Market Analysis by Type
4.1 Global Malaria Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Malaria Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Malaria Vaccines Price by Type (2016-2021)

5 Global Malaria Vaccines Historic Market Analysis by Application
5.1 Global Malaria Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Malaria Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Malaria Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline Plc
6.1.1 GlaxoSmithKline Plc Corporation Information
6.1.2 GlaxoSmithKline Plc Description and Business Overview
6.1.3 GlaxoSmithKline Plc Malaria Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Plc Product Portfolio
6.1.5 GlaxoSmithKline Plc Recent Developments/Updates
6.2 Sanaria Inc
6.2.1 Sanaria Inc Corporation Information
6.2.2 Sanaria Inc Description and Business Overview
6.2.3 Sanaria Inc Malaria Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanaria Inc Product Portfolio
6.2.5 Sanaria Inc Recent Developments/Updates
6.3 Nobelpharma Co
6.3.1 Nobelpharma Co Corporation Information
6.3.2 Nobelpharma Co Description and Business Overview
6.3.3 Nobelpharma Co Malaria Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Nobelpharma Co Product Portfolio
6.3.5 Nobelpharma Co Recent Developments/Updates
6.4 Sumaya Biotech
6.4.1 Sumaya Biotech Corporation Information
6.4.2 Sumaya Biotech Description and Business Overview
6.4.3 Sumaya Biotech Malaria Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sumaya Biotech Product Portfolio
6.4.5 Sumaya Biotech Recent Developments/Updates
6.5 GenVec
6.5.1 GenVec Corporation Information
6.5.2 GenVec Description and Business Overview
6.5.3 GenVec Malaria Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 GenVec Product Portfolio
6.5.5 GenVec Recent Developments/Updates

7 Malaria Vaccines Manufacturing Cost Analysis
7.1 Malaria Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Malaria Vaccines
7.4 Malaria Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Malaria Vaccines Distributors List
8.3 Malaria Vaccines Customers

9 Malaria Vaccines Market Dynamics
9.1 Malaria Vaccines Industry Trends
9.2 Malaria Vaccines Growth Drivers
9.3 Malaria Vaccines Market Challenges
9.4 Malaria Vaccines Market Restraints

10 Global Market Forecast
10.1 Malaria Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Malaria Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Malaria Vaccines by Type (2022-2027)
10.2 Malaria Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Malaria Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Malaria Vaccines by Application (2022-2027)
10.3 Malaria Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Malaria Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Malaria Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Malaria Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Malaria Vaccines Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Malaria Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Malaria Vaccines Covered in This Study
Table 5. Global Malaria Vaccines Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Malaria Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global Malaria Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Malaria Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Malaria Vaccines Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Malaria Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Malaria Vaccines Product Type
Table 12. Global Malaria Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Malaria Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malaria Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Malaria Vaccines Sales by Region (2016-2021) & (K Units)
Table 16. Global Malaria Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Malaria Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Malaria Vaccines Sales by Country (2016-2021) & (K Units)
Table 19. North America Malaria Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Malaria Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Malaria Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Malaria Vaccines Sales by Country (2016-2021) & (K Units)
Table 23. Europe Malaria Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Malaria Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Malaria Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Malaria Vaccines Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Malaria Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Malaria Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Malaria Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Malaria Vaccines Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Malaria Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Malaria Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Malaria Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Malaria Vaccines Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Malaria Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Malaria Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Malaria Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Malaria Vaccines Sales (K Units) by Type (2016-2021)
Table 39. Global Malaria Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Malaria Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Malaria Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Malaria Vaccines Price (USD/Unit) by Type (2016-2021)
Table 43. Global Malaria Vaccines Sales (K Units) by Application (2016-2021)
Table 44. Global Malaria Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Malaria Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Malaria Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Malaria Vaccines Price (USD/Unit) by Application (2016-2021)
Table 48. GlaxoSmithKline Plc Corporation Information
Table 49. GlaxoSmithKline Plc Description and Business Overview
Table 50. GlaxoSmithKline Plc Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Plc Malaria Vaccines Product
Table 52. GlaxoSmithKline Plc Recent Developments/Updates
Table 53. Sanaria Inc Corporation Information
Table 54. Sanaria Inc Description and Business Overview
Table 55. Sanaria Inc Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Sanaria Inc Malaria Vaccines Product
Table 57. Sanaria Inc Recent Developments/Updates
Table 58. Nobelpharma Co Corporation Information
Table 59. Nobelpharma Co Description and Business Overview
Table 60. Nobelpharma Co Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Nobelpharma Co Malaria Vaccines Product
Table 62. Nobelpharma Co Recent Developments/Updates
Table 63. Sumaya Biotech Corporation Information
Table 64. Sumaya Biotech Description and Business Overview
Table 65. Sumaya Biotech Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Sumaya Biotech Malaria Vaccines Product
Table 67. Sumaya Biotech Recent Developments/Updates
Table 68. GenVec Corporation Information
Table 69. GenVec Description and Business Overview
Table 70. GenVec Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. GenVec Malaria Vaccines Product
Table 72. GenVec Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Malaria Vaccines Distributors List
Table 76. Malaria Vaccines Customers List
Table 77. Malaria Vaccines Market Trends
Table 78. Malaria Vaccines Growth Drivers
Table 79. Malaria Vaccines Market Restraints
Table 80. Global Malaria Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 81. Global Malaria Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Malaria Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Malaria Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Malaria Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 85. Global Malaria Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Malaria Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Malaria Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Malaria Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 89. Global Malaria Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Malaria Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Malaria Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Malaria Vaccines
Figure 2. Global Malaria Vaccines Market Share by Type in 2020 & 2027
Figure 3. Pre-Erythrocytic Vaccine Product Picture
Figure 4. Erythrocytic Vaccine Product Picture
Figure 5. Multi-antigen Vaccine Product Picture
Figure 6. Global Malaria Vaccines Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Community Centers
Figure 10. Global Malaria Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Malaria Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Malaria Vaccines Sales 2016-2027 (K Units)
Figure 13. Global Malaria Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Malaria Vaccines Sales Share by Manufacturers in 2020
Figure 15. Global Malaria Vaccines Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Malaria Vaccines Players: Market Share by Revenue in 2020
Figure 17. Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Malaria Vaccines Sales Market Share by Region (2016-2021)
Figure 19. Global Malaria Vaccines Sales Market Share by Region in 2020
Figure 20. Global Malaria Vaccines Revenue Market Share by Region (2016-2021)
Figure 21. Global Malaria Vaccines Revenue Market Share by Region in 2020
Figure 22. U.S. Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Malaria Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Malaria Vaccines by Type (2016-2021)
Figure 47. Sales Market Share of Malaria Vaccines by Application (2016-2021)
Figure 48. Sales Market Share of Malaria Vaccines by Application in 2020
Figure 49. Revenue Share of Malaria Vaccines by Application (2016-2021)
Figure 50. Revenue Share of Malaria Vaccines by Application in 2020
Figure 51. Manufacturing Cost Structure of Malaria Vaccines
Figure 52. Manufacturing Process Analysis of Malaria Vaccines
Figure 53. Malaria Vaccines Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.